AKT1 and neoplasm: All‐trans retinoic acid (ATRA), an inducer of tumor stem cell differentiation, blocks the promotion of iRFA by inhibiting the phosphoinositide 3‐kinase (PI3K)/AKT pathway to trigger tumor‐initiating cell apoptosis.162